CEO
Inspiring Leaders | Dr Mehmood Khan
Dr Mehmood Khan is the CEO of Hevolution Foundation. He is also a pilot, physician, and a great believer in Michelangelo’s wise words “I...
Placement | Biocon Biologics Appoints Michael Cutter as Chief Quality Officer
Following a successful search, The RSA Group, a leading Life Sciences Executive Search and Executive Interims firm, is pleased to announce the placement of...
Successful Search | The RSA Group completes search for ReNeuron– Catherine Isted appointed as Chief Financial Officer
The RSA Group, a leading Life Sciences Executive Search firm, is pleased to announce the appointment of Catherine Isted as Chief Financial Officer at...
Inspiring Leaders | Charlotte Casebourne
Charlotte Casebourne is the co-founder and CEO of Theolytics, a company that quickly develops oncolytic (cancer-killing) viruses. Since spinning out of the University of...
Inside the Minds of People at the Cutting Edge of Life Science: How Great Leaders Think
Upcoming Webinar, free to attend We are excited to announce that our first Inspiring Leaders webinar will take place Thursday 13th May at 4pm...
Placement | The RSA Group completes successful search for Fusion Antibodies – Dr Richard Jones appointed as Chief Executive Officer
Following a successful search, The RSA Group is pleased to announce the placement of Dr Richard Jones as Chief Executive Officer at Fusion Antibodies,...
Inspiring Leaders | Dr Antonin de Fougerolles
With over 20 years of biotech R&D experience building out drug pipelines and helping drive several multi-billion-dollar companies from start-up, Tony is one of...
What will we need from life sciences leaders in 2021?
As a follow up to my recent blogs, I would like to share some further reflections about what Executive Leaders and Board members in...
Interim leaders are not ‘temps’ – choose wisely and reap the rewards
We’re all familiar with the concept – there’s an absence at work and we need some cover. A quick Google search and we send...
CRO talent: supplying scientific expertise
It’s hard to believe the speed of change in the preclinical CRO – pharma co. relationship over the recent years. Increasingly, preclinical contract research...